Eupraxia Pharmaceuticals reports Q3 results

1 hour ago 1

Eupraxia Pharmaceuticals press release (EPRX): The company incurred a net loss of $6.4 million for the three months ended September 30, 2025, versus a net loss of $6.0 million for the three months ended September 30, 2024. The increase in net loss was primarily